Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 232

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Identification of Serum Exosomal hsa-circ-0004771 as a Novel Diagnostic Biomarker of Colorectal Cancer

Open access
Pan, Bei, Qin, Jian, Liu, Xiangxiang, He, Bangshun, Wang, Xuhong, Pan, Yuqin, Sun, Huiling, Xu, Tao, Xu, Mu, Chen, Xiaoxiang, Xu, Xueni, Zeng, Kaixuan, Sun, Li, Wang, Shukui · 2019 · Frontiers in Genetics

Abstract

Background: Exosomal circular RNAs (circRNAs) in peripheral blood have been considered as promising diagnostic biomarkers of cancers. Due to the lack of sensitive and specific biomarkers, a large number of colorectal cancer (CRC) patients were diagnosed in the advanced stages leading to high mortality. This study aimed to identify circulating exosomal circRNAs as novel diagnostic biomarkers of CRC. Materials and methods: Candidate circRNA was selected by integrated analysis of Gene Expression Omnibus (GEO) database using online program GEO2R. Exosomes isolated from serums of participants and cell cultured media were confirmed by transmission electron microscope (TEM), nanosight particle tracking analysis and western blot. A total of 170 patients and 45 health controls were enrolled to assess the diagnostic value of circRNAs for CRC, and the expression and diagnostic utility of candidate were tested by qRT-PCR and receiver operating characteristic (ROC) analysis, respectively. Results: The circulating exosomal hsa-circ-0004771 with large differential fold change (≥1.5) as well as highest expression abundance was selected to further explore based on the results of GEO datasets analysis. The up-regulated exosomal hsa-circ-0004771 was further verified in serums of CRC patients compared to healthy controls (HCs) and patients with benign intestinal diseases (BIDs) by qRT-PCR. The area under the ROC curves (AUCs) of circulating exosomal hsa-circ-0004771 were 0.878 (95%CI, 0.815-0.940) and 0.859 (95%CI, 0.785-0.933) to differentiate CRC patients from HCs and CRC patients with early stage, and was 0.816 (95%CI, 0.73-0.90) to differentiate CRC patients with early stage from patients with BIDs. In addition, the elevated expression of exosomal hsa-circ-0004771 in serum of CRC patients was tumor-derived by the fact that the down-regulated expression of exosomal hsa-circ-0004771 was discovered in serum of postoperative CRC patients and cultured media of CRC cells treated with GW4869. Conclusions: Circulating exosomal hsa-circ-0004771 was significantly up-regulated in CRC patients and served as a novel potential early diagnostic biomarker of CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fgene.2019.01096

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 232

Metadata

Authors
Pan, B., Qin, J., Liu, X., He, B., Wang, X., Pan, Y., Sun, H., Xu, T., Xu, M., Chen, X., Xu, X., Zeng, K., Sun, L., & Wang, S.
Venue
Frontiers in Genetics
Published
2019-11-01
Volume
10
Pages
1096-1096
ISSN
1664-8021 (ISSN-L)
OpenAlex
W2989137800
Cited by
232
References
3
FWCI
9.17
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Serum Exosomal hsa-circ-0004771 as a Novel Diagnostic Biomarker of Colorectal Cancer. https://app.cochat.ai/papers/10.3389/fgene.2019.01096
The paper
Pan, B., Qin, J., Liu, X., He, B., Wang, X., Pan, Y., Sun, H., Xu, T., Xu, M., Chen, X., Xu, X., Zeng, K., Sun, L., & Wang, S. (2019). Identification of Serum Exosomal hsa-circ-0004771 as a Novel Diagnostic Biomarker of Colorectal Cancer. Frontiers in Genetics. https://doi.org/10.3389/fgene.2019.01096

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.